市場調査レポート

商品コード

1396848

グルクロノラクトン市場：タイプ別、用途別、エンドユーザー別：世界の機会分析と産業予測、2023年～2032年

Glucuronolactone Market By Type, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

出版日: 2023年09月30日 | 発行: Allied Market Research

| ページ情報: 英文 300 Pages | 納期: 2～3営業日

価格

PDF (Single User License)

USD 5,730 898,234円

レポートPDFを1つのPCでご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFの保存、表示、利用が可能です。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回だけ可能です。印刷したレポートの利用もPDFのライセンス保持者になります。回覧のための複製も原則NGです。

PDF (5-user License)

USD 6,450 1,011,102円

レポートPDFを5名でご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFの保存、表示、利用が可能です。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回可能です。印刷したレポートの利用もPDFのライセンス保持者5名となります。

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

USD 9,600 1,504,896円

レポートPDFとExcel定量データをひとつの企業、及びその子会社でご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFとExcelの保存、表示、利用が可能です。PDFとExcel内のテキスト等のコピー＆ペーストは可能です。PDFとExcelの印刷回数の制限はありません。印刷したレポートの利用は企業、及びその子会社内にて共有可能です。無料でレポートのアップデートがご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のグルクロノラクトン市場は、2023年から2032年までのCAGR 5.2%で、2022年の3億8,030万8,600米ドルから成長し、2032年には6億1,729万3,300米ドルに達すると予測されます。

グルクロノラクトンは食品に含まれる化学物質で、研究所でも製造されています。グルクロノラクトンは、エネルギー飲料、栄養補助食品、機能性飲料など、さまざまな消費者製品の成分として使用されています。グルクロノラクトンは、タウリンやカフェインと並んでサプリメントに含まれています。また、クレアチン、ベータアラニン、シトルリンなど、他のプレワークアウト物質と併用することもできます。グルクロノラクトンは、レッドブルのようなエナジードリンクや、多くのプレワークアウトサプリメント、脂肪減少プロテインに含まれる一般的な成分で、身体の強さと知的集中力を高めることが分かっています。

座りがちなライフスタイルや不健康な食生活の増加が、市場の成長を促進しています。Rockstar、Red Bull、Monsterのような即効性のあるエネルギー放出製品に対する需要の増加が市場拡大に寄与しています。さらに、クリーンラベルや植物由来の商品に対する需要の増加、健康的で活動的なライフスタイルへの志向の高まりが、予測期間を通じて市場拡大を促進すると予測されます。さらに、スポーツアイテムの宣伝のためにメーカーがインスタグラムやユーチューブなどのソーシャルメディア・プラットフォームの利用を増やしていることは、製品の人気を高めることで予測期間を通じて市場拡大を促進すると思われます。さらに、消費者の可処分所得の増加、スポーツ栄養への注目の高まりは、スポーツ栄養への意識の高まりと相まって、新製品の開発を後押しします。

グルクロノラクトンの価格が高いことや、グルクロノラクトンの過剰摂取によるさまざまな悪影響（見当識障害、めまい、速い心拍など）が市場成長の妨げになると予想されます。グルクロノラクトンのような栄養補助食品や機能性成分を取り巻く規制状況は進化しています。政府や規制機関は、安全性、有効性、正確な表示をより重視しています。規制が厳しくなるにつれ、グルクロノラクトン市場で事業を展開する企業は、製品に必要な承認や認証を取得する上で課題に直面する可能性があります。こうした規制上のハードルは、製品上市の遅延やコンプライアンスに関連する追加コストにつながり、市場の成長見通しを妨げる可能性があります。

医薬品への投資の増加がグルクロノラクトン業界の拡大に寄与しています。これは、医薬品の製造においてグルクロノラクトンの使用が増加しているためで、均一性やその他の特性を維持するための添加物として採用されています。グルクロノラクトンの主要企業による技術革新の高まりは、市場の成長を促進すると予想されます。例えば、2019年3月28日、市場をリードするコカ・コーラと直接競合するために、英国で初のエナジードリンクを発売し、グルクロノラクトンの需要を促進しています。カフェイン、グルクロノラクトン、ガラナ抽出物、ビタミンB群を含むこの新しい飲料は、18歳から35歳を対象としています。

COVID-19パンデミックは、グルクロノラクトン市場に大きな影響を与え、そのダイナミクスのさまざまな側面に影響を与えました。グルクロノラクトンの生産に必要な原材料の調達に影響を与えるロックダウン、渡航制限、労働力の減少など、サプライチェーンの混乱が重大な課題として浮上しました。これらの混乱は、製造施設の閉鎖や、安全衛生プロトコルによる操業能力の低下と相まって、グルクロノラクトン含有製品の生産停止と潜在的な供給不足につながっています。パンデミックによる消費者の健康志向へのシフトは、栄養補助食品やグルクロノラクトンのような機能性成分の需要にさらに影響を与えました。免疫力や健康全般をサポートする製品を求める消費者が増えており、市場は需要の変動を経験しました。さらに、実店舗の閉鎖により、製品の流通におけるオンライン販売チャネルへの依存度が高まり、業界内のeコマースへの動向が加速しました。

市場の定義と範囲
主な調査結果
- 影響要因
- 主な投資機会
ポーターのファイブフォース分析
市場力学
- 促進要因
- 抑制要因
- 機会
平均販売価格
市場シェア分析
ブランドシェア分析
貿易データ分析
製品消費
バリューチェーン分析
規制ガイドライン
主要規制分析
償還シナリオ
特許情勢

第4章グルクロノラクトン市場：タイプ別

概要
粉末
液体
錠剤/カプセル

第5章グルクロノラクトン市場：用途別

概要
防腐剤
酸化防止剤
加工助剤・添加剤
エネルギーサプリメント

第6章グルクロノラクトン市場：エンドユーザー別

概要
飲食品
医薬品

第7章グルクロノラクトン市場：地域別

概要
北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- 英国
- フランス
- スペイン
- イタリア
- その他
アジア太平洋
- 中国
- 日本
- インド
- 韓国
- オーストラリア
- その他
ラテンアメリカ・中東・アフリカ
- ブラジル
- サウジアラビア
- アラブ首長国連邦
- 南アフリカ
- その他

第8章競争情勢

イントロダクション
主要成功戦略
主要10企業の製品マッピング
競合ダッシュボード
競合ヒートマップ
主要企業のポジショニング、2022年

第9章企業プロファイル

Jungbunzlauer
Shandong Xinhong Pharmaceutical Co., Ltd.
Shandong Fuyuan Bio-Tech CO.LTD.
Merck Millipore Corporation
Shaoxing Marina Biotechnology Co.Ltd.
Shandong Baisheng Biotechnology Co., Ltd.
Roquette Freres
Functional Food chem International Corporation
Hubei Yitai Pharmaceutical Co.Ltd.
Anhui Fubore Pharmaceutical & Chemical Co.Ltd.

図表

LIST OF TABLES

TABLE 01. GLOBAL GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 02. GLUCURONOLACTONE MARKET FOR POWDER, BY REGION, 2022-2032 ($THOUSAND)
TABLE 03. GLUCURONOLACTONE MARKET FOR LIQUID, BY REGION, 2022-2032 ($THOUSAND)
TABLE 04. GLUCURONOLACTONE MARKET FOR TABLET/CAPSULE, BY REGION, 2022-2032 ($THOUSAND)
TABLE 05. GLOBAL GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 06. GLUCURONOLACTONE MARKET FOR PRESERVATIVES, BY REGION, 2022-2032 ($THOUSAND)
TABLE 07. GLUCURONOLACTONE MARKET FOR ANTIOXIDANTS, BY REGION, 2022-2032 ($THOUSAND)
TABLE 08. GLUCURONOLACTONE MARKET FOR PROCESSING AIDS AND ADDITIVES, BY REGION, 2022-2032 ($THOUSAND)
TABLE 09. GLUCURONOLACTONE MARKET FOR ENERGY SUPPLEMENTS, BY REGION, 2022-2032 ($THOUSAND)
TABLE 10. GLOBAL GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 11. GLUCURONOLACTONE MARKET FOR FOOD AND BEVERAGES, BY REGION, 2022-2032 ($THOUSAND)
TABLE 12. GLUCURONOLACTONE MARKET FOR PHARMACEUTICALS, BY REGION, 2022-2032 ($THOUSAND)
TABLE 13. GLUCURONOLACTONE MARKET, BY REGION, 2022-2032 ($THOUSAND)
TABLE 14. NORTH AMERICA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 15. NORTH AMERICA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 16. NORTH AMERICA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 17. NORTH AMERICA GLUCURONOLACTONE MARKET, BY COUNTRY, 2022-2032 ($THOUSAND)
TABLE 18. U.S. GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 19. U.S. GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 20. U.S. GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 21. CANADA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 22. CANADA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 23. CANADA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 24. MEXICO GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 25. MEXICO GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 26. MEXICO GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 27. EUROPE GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 28. EUROPE GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 29. EUROPE GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 30. EUROPE GLUCURONOLACTONE MARKET, BY COUNTRY, 2022-2032 ($THOUSAND)
TABLE 31. GERMANY GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 32. GERMANY GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 33. GERMANY GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 34. UK GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 35. UK GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 36. UK GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 37. FRANCE GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 38. FRANCE GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 39. FRANCE GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 40. SPAIN GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 41. SPAIN GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 42. SPAIN GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 43. ITALY GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 44. ITALY GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 45. ITALY GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 46. REST OF EUROPE GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 47. REST OF EUROPE GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 48. REST OF EUROPE GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 49. ASIA-PACIFIC GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 50. ASIA-PACIFIC GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 51. ASIA-PACIFIC GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 52. ASIA-PACIFIC GLUCURONOLACTONE MARKET, BY COUNTRY, 2022-2032 ($THOUSAND)
TABLE 53. CHINA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 54. CHINA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 55. CHINA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 56. JAPAN GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 57. JAPAN GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 58. JAPAN GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 59. INDIA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 60. INDIA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 61. INDIA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 62. SOUTH KOREA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 63. SOUTH KOREA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 64. SOUTH KOREA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 65. AUSTRALIA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 66. AUSTRALIA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 67. AUSTRALIA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 68. REST OF ASIA-PACIFIC GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 69. REST OF ASIA-PACIFIC GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 70. REST OF ASIA-PACIFIC GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 71. LAMEA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 72. LAMEA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 73. LAMEA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 74. LAMEA GLUCURONOLACTONE MARKET, BY COUNTRY, 2022-2032 ($THOUSAND)
TABLE 75. BRAZIL GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 76. BRAZIL GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 77. BRAZIL GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 78. SAUDI ARABIA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 79. SAUDI ARABIA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 80. SAUDI ARABIA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 81. UNITED ARAB EMIRATES GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 82. UNITED ARAB EMIRATES GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 83. UNITED ARAB EMIRATES GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 84. SOUTH AFRICA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 85. SOUTH AFRICA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 86. SOUTH AFRICA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 87. REST OF LAMEA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
TABLE 88. REST OF LAMEA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
TABLE 89. REST OF LAMEA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
TABLE 90. JUNGBUNZLAUER: KEY EXECUTIVES
TABLE 91. JUNGBUNZLAUER: COMPANY SNAPSHOT
TABLE 92. SHANDONG XINHONG PHARMACEUTICAL CO., LTD.: KEY EXECUTIVES
TABLE 93. SHANDONG XINHONG PHARMACEUTICAL CO., LTD.: COMPANY SNAPSHOT
TABLE 94. SHANDONG FUYUAN BIO-TECH CO.LTD.: KEY EXECUTIVES
TABLE 95. SHANDONG FUYUAN BIO-TECH CO.LTD.: COMPANY SNAPSHOT
TABLE 96. MERCK MILLIPORE CORPORATION: KEY EXECUTIVES
TABLE 97. MERCK MILLIPORE CORPORATION: COMPANY SNAPSHOT
TABLE 98. SHAOXING MARINA BIOTECHNOLOGY CO.LTD.: KEY EXECUTIVES
TABLE 99. SHAOXING MARINA BIOTECHNOLOGY CO.LTD.: COMPANY SNAPSHOT
TABLE 100. SHANDONG BAISHENG BIOTECHNOLOGY CO., LTD.: KEY EXECUTIVES
TABLE 101. SHANDONG BAISHENG BIOTECHNOLOGY CO., LTD.: COMPANY SNAPSHOT
TABLE 102. ROQUETTE FRERES: KEY EXECUTIVES
TABLE 103. ROQUETTE FRERES: COMPANY SNAPSHOT
TABLE 104. FUNCTIONAL FOOD CHEM INTERNATIONAL CORPORATION: KEY EXECUTIVES
TABLE 105. FUNCTIONAL FOOD CHEM INTERNATIONAL CORPORATION: COMPANY SNAPSHOT
TABLE 106. HUBEI YITAI PHARMACEUTICAL CO.LTD.: KEY EXECUTIVES
TABLE 107. HUBEI YITAI PHARMACEUTICAL CO.LTD.: COMPANY SNAPSHOT
TABLE 108. ANHUI FUBORE PHARMACEUTICAL & CHEMICAL CO.LTD.: KEY EXECUTIVES
TABLE 109. ANHUI FUBORE PHARMACEUTICAL & CHEMICAL CO.LTD.: COMPANY SNAPSHOT

LIST OF FIGURES

FIGURE 01. GLUCURONOLACTONE MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF GLUCURONOLACTONE MARKET,2022-2032
FIGURE 03. TOP INVESTMENT POCKETS IN GLUCURONOLACTONE MARKET (2023-2032)
FIGURE 04. BARGAINING POWER OF SUPPLIERS
FIGURE 05. BARGAINING POWER OF BUYERS
FIGURE 06. THREAT OF SUBSTITUTION
FIGURE 07. THREAT OF SUBSTITUTION
FIGURE 08. COMPETITIVE RIVALRY
FIGURE 09. GLOBAL GLUCURONOLACTONE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 10. REGULATORY GUIDELINES: GLUCURONOLACTONE MARKET
FIGURE 11. IMPACT OF KEY REGULATION: GLUCURONOLACTONE MARKET
FIGURE 12. PATENT ANALYSIS BY COMPANY
FIGURE 13. PATENT ANALYSIS BY COUNTRY
FIGURE 14. GLUCURONOLACTONE MARKET, BY TYPE, 2022 AND 2032(%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF GLUCURONOLACTONE MARKET FOR POWDER, BY COUNTRY 2022 AND 2032(%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF GLUCURONOLACTONE MARKET FOR LIQUID, BY COUNTRY 2022 AND 2032(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF GLUCURONOLACTONE MARKET FOR TABLET/CAPSULE, BY COUNTRY 2022 AND 2032(%)
FIGURE 18. GLUCURONOLACTONE MARKET, BY APPLICATION, 2022 AND 2032(%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF GLUCURONOLACTONE MARKET FOR PRESERVATIVES, BY COUNTRY 2022 AND 2032(%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF GLUCURONOLACTONE MARKET FOR ANTIOXIDANTS, BY COUNTRY 2022 AND 2032(%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF GLUCURONOLACTONE MARKET FOR PROCESSING AIDS AND ADDITIVES, BY COUNTRY 2022 AND 2032(%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF GLUCURONOLACTONE MARKET FOR ENERGY SUPPLEMENTS, BY COUNTRY 2022 AND 2032(%)
FIGURE 23. GLUCURONOLACTONE MARKET, BY END USER, 2022 AND 2032(%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF GLUCURONOLACTONE MARKET FOR FOOD AND BEVERAGES, BY COUNTRY 2022 AND 2032(%)
FIGURE 25. COMPARATIVE SHARE ANALYSIS OF GLUCURONOLACTONE MARKET FOR PHARMACEUTICALS, BY COUNTRY 2022 AND 2032(%)
FIGURE 26. GLUCURONOLACTONE MARKET BY REGION, 2022 AND 2032(%)
FIGURE 27. U.S. GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
FIGURE 28. CANADA GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
FIGURE 29. MEXICO GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
FIGURE 30. GERMANY GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
FIGURE 31. UK GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
FIGURE 32. FRANCE GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
FIGURE 33. SPAIN GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
FIGURE 34. ITALY GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
FIGURE 35. REST OF EUROPE GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
FIGURE 36. CHINA GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
FIGURE 37. JAPAN GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
FIGURE 38. INDIA GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
FIGURE 39. SOUTH KOREA GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
FIGURE 40. AUSTRALIA GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
FIGURE 41. REST OF ASIA-PACIFIC GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
FIGURE 42. BRAZIL GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
FIGURE 43. SAUDI ARABIA GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
FIGURE 44. UNITED ARAB EMIRATES GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
FIGURE 45. SOUTH AFRICA GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
FIGURE 46. REST OF LAMEA GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
FIGURE 47. TOP WINNING STRATEGIES, BY YEAR
FIGURE 48. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 49. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 50. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 51. COMPETITIVE DASHBOARD
FIGURE 52. COMPETITIVE HEATMAP: GLUCURONOLACTONE MARKET
FIGURE 53. TOP PLAYER POSITIONING, 2022

Product Code: A13550

The global glucuronolactone market is anticipated to reach $6,17,293.3 thousand by 2032, growing from $3,80,308.6 thousand in 2022 at a CAGR of 5.2% from 2023 to 2032.

Glucuronolactone is a chemical found in food products and is also manufactured in laboratories. Glucuronolactone is used as an ingredient in various consumer products, including some energy drinks, dietary supplements, and functional beverages... Glucuronolactone is included in supplements alongside taurine and caffeine. It can also be used in conjunction with other pre-workout substances like as creatine, beta-alanine, and citrulline. Glucuronolactone is a common ingredient found in many energy drinks such as Red bull and a number of pre-workout supplements, and fat-loss proteins, and it is found to increase bodily strength and intellectual focus.

A growing sedentary lifestyle and consumption of an unhealthy diet are driving market growth. The increasing demand for immediate energy-releasing products such as Rockstar, Red Bull, and Monster has contributed to market expansion. Furthermore, increased demand for clean-label and plant-based goods, as well as a growing inclination for a healthy, active lifestyle, are predicted to drive market expansion throughout the projection period. Furthermore, the increased usage of social media platforms such as Instagram and YouTube by manufacturers to advertise sports items is likely to drive market expansion throughout the forecast period by increasing the popularity of products. Moreover, the increasing disposable income of the consumers, and rising focus on sports nutrition encourage new product development, coupled with the rising awareness of sports nutrition.

The high glucuronolactone prices and different adverse impacts of excessive glucuronolactone intake, like disorientation, dizziness, and fast heartbeat, are expected to hamper market growth. The regulatory landscape surrounding dietary supplements and functional ingredients like glucuronolactone is evolving. Governments and regulatory bodies are placing greater emphasis on safety, efficacy, and accurate labeling. As regulations become more stringent, companies operating in the glucuronolactone market might face challenges in obtaining the necessary approvals and certifications for their products. These regulatory hurdles can lead to delays in product launches and additional costs associated with compliance, hindering the growth prospects of the market.

Rising pharmaceutical investments are contributing to the glucuronolactone industry's expansion. This can be due to the growing use of glucuronolactone in medicine manufacture, where it is employed as an addition to preserve uniformity and other properties. Rising innovation by key companies in glucuronolactone is expected to drive market growth. For instance, on 28 March 2019, to compete directly with market leaders Coca Cola launched its first energy drink in the United Kingdom, driving demand for glucuronolactone. The new drink, which contains caffeine, glucuronolactone, guarana extracts, and B vitamins, is intended for those aged 18 to 35.

The COVID-19 pandemic has had significant impacts on the market for glucuronolactone, influencing various aspects of its dynamics. Supply chain disruptions emerged as a significant challenge, with lockdowns, restrictions on travel, and reduced workforce availability affecting the sourcing of raw materials necessary for glucuronolactone production. These disruptions, combined with manufacturing facility closures and reduced operational capacities due to health and safety protocols, led to production slowdowns and potential shortages of glucuronolactone-containing products. The pandemic-induced shift in consumer behavior towards health and wellness further influenced the demand for dietary supplements and functional ingredients like glucuronolactone. With consumers increasingly seeking products that support immunity and overall well-being, the market experienced fluctuations in demand. Additionally, the closure of physical retail outlets prompted a greater reliance on online sales channels for distributing products, accelerating the trend towards e-commerce within the industry.

The key players profiled in this report include Anhui Fubore Pharmaceutical & Chemical Co.Ltd., Hubei Yitai Pharmaceutical Co.Ltd., Shandong Fuyuan Bio-Tech CO.LTD., Shandong Baisheng Biotechnology Co., Ltd., Functional Food chem International Corporation, Shaoxing Marina Biotechnology Co.Ltd., Merck Millipore Corporation, Jungbunzlauer, Shandong Xinhong Pharmaceutical Co., Ltd., Roquette Freres. The market players are continuously striving to achieve an upper hand in this competitive market using strategies such as collaborations and acquisitions.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the glucuronolactone market analysis from 2022 to 2032 to identify the prevailing glucuronolactone market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the glucuronolactone market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global glucuronolactone market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

Investment Opportunities
Supply Chain Analysis & Vendor Margins
Technology Trend Analysis
Consumer Preference and Product Specifications
Market share analysis of players by products/segments
Regulatory Guidelines
Additional company profiles with specific to client's interest
Additional country or region analysis- market size and forecast
Criss-cross segment analysis- market size and forecast
Expanded list for Company Profiles
Historic market data
Key player details (including location, contact details, supplier/vendor network etc. in excel format)
Market share analysis of players at global/region/country level
SWOT Analysis

Key Market Segments

By Type

Powder
Liquid
Tablet/Capsule

By Application

Preservatives
Antioxidants
Processing Aids and Additives
Energy Supplements

By End User

Food and Beverages
Pharmaceuticals

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- United Arab Emirates
- South Africa
- Rest of LAMEA

Key Market Players:

Jungbunzlauer
Shandong Xinhong Pharmaceutical Co., Ltd.
Shandong Fuyuan Bio-Tech CO.LTD.
Merck Millipore Corporation
Shaoxing Marina Biotechnology Co.Ltd.
Shandong Baisheng Biotechnology Co., Ltd.
Roquette Freres
Functional Food chem International Corporation
Hubei Yitai Pharmaceutical Co.Ltd.
Anhui Fubore Pharmaceutical & Chemical Co.Ltd.

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
3.3. Porter's five forces analysis
3.4. Market dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
3.5. Average Selling Price
3.6. Market Share Analysis
3.7. Brand Share Analysis
3.8. Trade Data Analysis
3.9. Product Consumption
3.10. Value Chain Analysis
3.11. Regulatory Guidelines
3.12. Key Regulation Analysis
3.13. Reimbursement Scenario
3.14. Patent Landscape

CHAPTER 4: GLUCURONOLACTONE MARKET, BY TYPE

4.1. Overview
- 4.1.1. Market size and forecast
4.2. Powder
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
4.3. Liquid
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
4.4. Tablet/Capsule
- 4.4.1. Key market trends, growth factors and opportunities
- 4.4.2. Market size and forecast, by region
- 4.4.3. Market share analysis by country

CHAPTER 5: GLUCURONOLACTONE MARKET, BY APPLICATION

5.1. Overview
- 5.1.1. Market size and forecast
5.2. Preservatives
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
5.3. Antioxidants
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
5.4. Processing Aids and Additives
- 5.4.1. Key market trends, growth factors and opportunities
- 5.4.2. Market size and forecast, by region
- 5.4.3. Market share analysis by country
5.5. Energy Supplements
- 5.5.1. Key market trends, growth factors and opportunities
- 5.5.2. Market size and forecast, by region
- 5.5.3. Market share analysis by country

CHAPTER 6: GLUCURONOLACTONE MARKET, BY END USER

6.1. Overview
- 6.1.1. Market size and forecast
6.2. Food and Beverages
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
6.3. Pharmaceuticals
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country

CHAPTER 7: GLUCURONOLACTONE MARKET, BY REGION

7.1. Overview
- 7.1.1. Market size and forecast By Region
7.2. North America
- 7.2.1. Key market trends, growth factors and opportunities
- 7.2.2. Market size and forecast, by Type
- 7.2.3. Market size and forecast, by Application
- 7.2.4. Market size and forecast, by End User
- 7.2.5. Market size and forecast, by country
  - 7.2.5.1. U.S.
  - 7.2.5.1.1. Market size and forecast, by Type
  - 7.2.5.1.2. Market size and forecast, by Application
  - 7.2.5.1.3. Market size and forecast, by End User
  - 7.2.5.2. Canada
  - 7.2.5.2.1. Market size and forecast, by Type
  - 7.2.5.2.2. Market size and forecast, by Application
  - 7.2.5.2.3. Market size and forecast, by End User
  - 7.2.5.3. Mexico
  - 7.2.5.3.1. Market size and forecast, by Type
  - 7.2.5.3.2. Market size and forecast, by Application
  - 7.2.5.3.3. Market size and forecast, by End User
7.3. Europe
- 7.3.1. Key market trends, growth factors and opportunities
- 7.3.2. Market size and forecast, by Type
- 7.3.3. Market size and forecast, by Application
- 7.3.4. Market size and forecast, by End User
- 7.3.5. Market size and forecast, by country
  - 7.3.5.1. Germany
  - 7.3.5.1.1. Market size and forecast, by Type
  - 7.3.5.1.2. Market size and forecast, by Application
  - 7.3.5.1.3. Market size and forecast, by End User
  - 7.3.5.2. UK
  - 7.3.5.2.1. Market size and forecast, by Type
  - 7.3.5.2.2. Market size and forecast, by Application
  - 7.3.5.2.3. Market size and forecast, by End User
  - 7.3.5.3. France
  - 7.3.5.3.1. Market size and forecast, by Type
  - 7.3.5.3.2. Market size and forecast, by Application
  - 7.3.5.3.3. Market size and forecast, by End User
  - 7.3.5.4. Spain
  - 7.3.5.4.1. Market size and forecast, by Type
  - 7.3.5.4.2. Market size and forecast, by Application
  - 7.3.5.4.3. Market size and forecast, by End User
  - 7.3.5.5. Italy
  - 7.3.5.5.1. Market size and forecast, by Type
  - 7.3.5.5.2. Market size and forecast, by Application
  - 7.3.5.5.3. Market size and forecast, by End User
  - 7.3.5.6. Rest of Europe
  - 7.3.5.6.1. Market size and forecast, by Type
  - 7.3.5.6.2. Market size and forecast, by Application
  - 7.3.5.6.3. Market size and forecast, by End User
7.4. Asia-Pacific
- 7.4.1. Key market trends, growth factors and opportunities
- 7.4.2. Market size and forecast, by Type
- 7.4.3. Market size and forecast, by Application
- 7.4.4. Market size and forecast, by End User
- 7.4.5. Market size and forecast, by country
  - 7.4.5.1. China
  - 7.4.5.1.1. Market size and forecast, by Type
  - 7.4.5.1.2. Market size and forecast, by Application
  - 7.4.5.1.3. Market size and forecast, by End User
  - 7.4.5.2. Japan
  - 7.4.5.2.1. Market size and forecast, by Type
  - 7.4.5.2.2. Market size and forecast, by Application
  - 7.4.5.2.3. Market size and forecast, by End User
  - 7.4.5.3. India
  - 7.4.5.3.1. Market size and forecast, by Type
  - 7.4.5.3.2. Market size and forecast, by Application
  - 7.4.5.3.3. Market size and forecast, by End User
  - 7.4.5.4. South Korea
  - 7.4.5.4.1. Market size and forecast, by Type
  - 7.4.5.4.2. Market size and forecast, by Application
  - 7.4.5.4.3. Market size and forecast, by End User
  - 7.4.5.5. Australia
  - 7.4.5.5.1. Market size and forecast, by Type
  - 7.4.5.5.2. Market size and forecast, by Application
  - 7.4.5.5.3. Market size and forecast, by End User
  - 7.4.5.6. Rest of Asia-Pacific
  - 7.4.5.6.1. Market size and forecast, by Type
  - 7.4.5.6.2. Market size and forecast, by Application
  - 7.4.5.6.3. Market size and forecast, by End User
7.5. LAMEA
- 7.5.1. Key market trends, growth factors and opportunities
- 7.5.2. Market size and forecast, by Type
- 7.5.3. Market size and forecast, by Application
- 7.5.4. Market size and forecast, by End User
- 7.5.5. Market size and forecast, by country
  - 7.5.5.1. Brazil
  - 7.5.5.1.1. Market size and forecast, by Type
  - 7.5.5.1.2. Market size and forecast, by Application
  - 7.5.5.1.3. Market size and forecast, by End User
  - 7.5.5.2. Saudi Arabia
  - 7.5.5.2.1. Market size and forecast, by Type
  - 7.5.5.2.2. Market size and forecast, by Application
  - 7.5.5.2.3. Market size and forecast, by End User
  - 7.5.5.3. United Arab Emirates
  - 7.5.5.3.1. Market size and forecast, by Type
  - 7.5.5.3.2. Market size and forecast, by Application
  - 7.5.5.3.3. Market size and forecast, by End User
  - 7.5.5.4. South Africa
  - 7.5.5.4.1. Market size and forecast, by Type
  - 7.5.5.4.2. Market size and forecast, by Application
  - 7.5.5.4.3. Market size and forecast, by End User
  - 7.5.5.5. Rest of LAMEA
  - 7.5.5.5.1. Market size and forecast, by Type
  - 7.5.5.5.2. Market size and forecast, by Application
  - 7.5.5.5.3. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

9.1. Jungbunzlauer
- 9.1.1. Company overview
- 9.1.2. Key Executives
- 9.1.3. Company snapshot
9.2. Shandong Xinhong Pharmaceutical Co., Ltd.
- 9.2.1. Company overview
- 9.2.2. Key Executives
- 9.2.3. Company snapshot
9.3. Shandong Fuyuan Bio-Tech CO.LTD.
- 9.3.1. Company overview
- 9.3.2. Key Executives
- 9.3.3. Company snapshot
9.4. Merck Millipore Corporation
- 9.4.1. Company overview
- 9.4.2. Key Executives
- 9.4.3. Company snapshot
9.5. Shaoxing Marina Biotechnology Co.Ltd.
- 9.5.1. Company overview
- 9.5.2. Key Executives
- 9.5.3. Company snapshot
9.6. Shandong Baisheng Biotechnology Co., Ltd.
- 9.6.1. Company overview
- 9.6.2. Key Executives
- 9.6.3. Company snapshot
9.7. Roquette Freres
- 9.7.1. Company overview
- 9.7.2. Key Executives
- 9.7.3. Company snapshot
9.8. Functional Food chem International Corporation
- 9.8.1. Company overview
- 9.8.2. Key Executives
- 9.8.3. Company snapshot
9.9. Hubei Yitai Pharmaceutical Co.Ltd.
- 9.9.1. Company overview
- 9.9.2. Key Executives
- 9.9.3. Company snapshot
9.10. Anhui Fubore Pharmaceutical & Chemical Co.Ltd.
- 9.10.1. Company overview
- 9.10.2. Key Executives
- 9.10.3. Company snapshot

グルクロノラクトン市場：タイプ別、用途別、エンドユーザー別：世界の機会分析と産業予測、2023年～2032年

Glucuronolactone Market By Type, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場概要

第4章グルクロノラクトン市場：タイプ別

第5章グルクロノラクトン市場：用途別

第6章グルクロノラクトン市場：エンドユーザー別

第7章グルクロノラクトン市場：地域別

第8章競争情勢

第9章企業プロファイル

LIST OF TABLES

LIST OF FIGURES

Key Benefits For Stakeholders

Key Market Segments

By Type

By Application

By End User

By Region

Key Market Players:

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

CHAPTER 2: EXECUTIVE SUMMARY

CHAPTER 3: MARKET OVERVIEW

CHAPTER 4: GLUCURONOLACTONE MARKET, BY TYPE

CHAPTER 5: GLUCURONOLACTONE MARKET, BY APPLICATION

CHAPTER 6: GLUCURONOLACTONE MARKET, BY END USER

CHAPTER 7: GLUCURONOLACTONE MARKET, BY REGION

CHAPTER 8: COMPETITIVE LANDSCAPE

CHAPTER 9: COMPANY PROFILES

グルクロノラクトン市場：タイプ別、用途別、エンドユーザー別：世界の機会分析と産業予測、2023年～2032年

Glucuronolactone Market By Type, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

第4章 グルクロノラクトン市場：タイプ別

第5章 グルクロノラクトン市場：用途別

第6章 グルクロノラクトン市場：エンドユーザー別

第7章 グルクロノラクトン市場：地域別

第8章 競争情勢

第9章 企業プロファイル

LIST OF TABLES

LIST OF FIGURES

Key Benefits For Stakeholders

Key Market Segments

By Type

By Application

By End User

By Region

Key Market Players:

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

CHAPTER 2: EXECUTIVE SUMMARY

CHAPTER 3: MARKET OVERVIEW

CHAPTER 4: GLUCURONOLACTONE MARKET, BY TYPE

CHAPTER 5: GLUCURONOLACTONE MARKET, BY APPLICATION

CHAPTER 6: GLUCURONOLACTONE MARKET, BY END USER

CHAPTER 7: GLUCURONOLACTONE MARKET, BY REGION

CHAPTER 8: COMPETITIVE LANDSCAPE

CHAPTER 9: COMPANY PROFILES

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場概要

第4章グルクロノラクトン市場：タイプ別

第5章グルクロノラクトン市場：用途別

第6章グルクロノラクトン市場：エンドユーザー別

第7章グルクロノラクトン市場：地域別

第8章競争情勢

第9章企業プロファイル